Third consensus on medical treatment of metastatic breast cancer (2009)
Beslija, S., Bonneterre, J., Burstein, H. J., Cocquyt, V., Gnant, M., Heinemann, V., ...
Background: Treatment options for patients with metastatic breast cancer (MBC) include a rapidly expanding repertoire of medical, surgical and supportive care measures. Design: To provide timely and...
Second consensus on medical treatment of metastatic breast cancer (2007)
Beslija, S, Bonneterre, J, Burstein, H, Cocquyt, V, Gnant, M, Goodwin, P, ...
The present consensus manuscript defines evidence-based recommendations for state-of-the-art treatment of metastatic breast cancer depending on disease-associated and biologic variables.
Second consensus on medical treatment of metastatic breast cancer (2006)
Beslija, S., Bonneterre, J., Burstein, H., Cocquyt, V., Gnant, M., Goodwin, P., ...
The present consensus manuscript defines evidence-based recommendations for state-of-the-art treatment of metastatic breast cancer depending on disease-associated and biologic variables.
Neyt, M., Albrecht, J., Cocquyt, V.
Background: Herceptin® (trastuzumab) is a humanized monoclonal antibody that is being tested in the adjuvant setting. Cost implications of using trastuzumab, as administered in the Breast Cancer...
Second consensus on medical treatment of metastatic breast cancer (2006)
Beslija, S., Bonneterre, J., Burstein, H., Cocquyt, V., Gnant, M., Goodwin, P., ...
The present consensus manuscript defines evidence-based recommendations for state-of-the-art treatment of metastatic breast cancer depending on disease-associated and biologic variables.
Lack of effect of aprepitant on the pharmacokinetics of docetaxel in cancer patients (2005)
Nygren, P, Hande, K, Petty, KJ, Fedgchin, M, Van Dyck, K, Majumdar, A, ...
Background: Aprepitant is a selective neurokinin-1 receptor antagonist that is effective for the prevention of nausea and vomiting caused by highly emetogenic chemotherapy. In vitro, aprepitant is a...
Neyt, M., Albrecht, J., Cocquyt, V.
Background: Herceptin® (trastuzumab) is a humanized monoclonal antibody that is being tested in the adjuvant setting. Cost implications of using trastuzumab, as administered in the Breast Cancer...
Di Leo, A., Chan, S., Paesmans, M., Friedrichs, K., Pinter, T., Cocquyt, V., ...
Purpose: To evaluate the predictive value of HER-2 in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin (A) or with single-agent docetaxel (T)....
Cocquyt, V, Blondeel, P, Depypere, H, Daems, K, Monstrey, S, ...
Preoperative chemotherapy (PCT) can be used in Large primary breast cancer to facilitate breast conservative surgery (BCS). Cosmetic results of BCS are influenced by the size of the residual tumour,...
Van Aelst, F, Georgoulias, V, Samonnig, H, Cocquyt, V, Zielinski, C, ...
BACKGROUND: This phase II study evaluated the feasibility and efficacy of alternating and sequential regimens of docetaxel and doxorubicin as first-line chemotherapy for metastatic breast cancer...
Long-term medical costs of postmenopausal breast cancer therapy (2003)
Cocquyt, V., Moeremans, K., Annemans, L., Clarys, P., Van Belle, S.
Background: Since the incidence of breast cancer is growing, prevention programs can be expected to have a large economic impact on the health care system. From a health economic point of view, one...
Paridaens, R., Van Aelst, F., Georgoulias, V., Samonnig, H., Cocquyt, V., Zielinski, C., ...
Background: This phase II study evaluated the feasibility and efficacy of alternating and sequential regimens of docetaxel and doxorubicin as first-line chemotherapy for metastatic breast cancer...
Mutation analysis of P73 and TP53 in Merkel cell carcinoma (2000)
Kaghad, M, Leonard, J H, Van Roy, N, Naeyaert, J M, Geerts, M L, ...
The p73 gene has been mapped to 1p36.33, a region which is frequently deleted in a wide variety of neoplasms including tumours of neuroectodermal origin. The p73 protein shows structural and...
Mutation analysis of P73 and TP53 in Merkel cell carcinoma (2000)
Van Gele, M, Kaghad, M, Leonard, JH, Van Roy, N, Naeyaert, JM, Geerts, ML, ...
The p73 gene has been mapped to 1p36.33, a region which is frequently deleted in a wide variety of neoplasms including tumours of neuroectodermal origin, The p73 protein shows structural and...
Abdominal pain with anorexia in patients with breast carcinoma (1998)
Van Trappen, Ph., Serreyn, R., Elewaut, A. E., Cocquyt, V., Van Belle, S.
Breast cancer is the second commonest primary tumour responsible for gastrointestinal metastases after malignant melanoma. The real incidence of gastrointestinal metastases in breast cancer patients...
Mutation analysis of P73 and TP53 in Merkel cell carcinoma
Gele, M Van, Kaghad, M, Leonard, J H, Roy, N Van, Naeyaert, J M, Geerts, M L, ...
The p73 gene has been mapped to 1p36.33, a region which is frequently deleted in a wide variety of neoplasms including tumours of neuroectodermal origin. The p73 protein shows structural and...